AcuCort AB financing round is a huge sucess

AcuCort AB has today announced the final result of the rights issue, and with a subscription rate of 160 %, it was heavily oversubscriped, which is rarely seen these days. AcuCort AB will be receiving 47,7 mio. SEK brutto and at least 41 mio. SEK netto.
As previously communicated, in line with our long-term partner strategy, LSIF has also been a major investor also in this round and we are extremely pleased to see the both broad and deep support, AcuCort AB has received in this round, enabling the company to focus on driving business forward. We have high expectations to 2025 for AcuCort AB and we look forward to the commercial journey ahead.
The financial advisor on this transaction was Stockholm Corporate Finance.